Evidence map›Paper›PMID 34542713›Full record

ArticleNanoscale research letters2021

Biogenic Synthesis, Characterization and Antibacterial Potential Evaluation of Copper Oxide Nanoparticles Against Escherichia coli.

Mohsin Ali, Muhammad Ijaz, Muhammad Ikram, Anwar Ul-Hamid, Muhammad Avais, Aftab Ahmad Anjum

Abstract read
In one paragraph

Article in Nanoscale research letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Anthelmintic Activity and Pathophysiological Effect ofJournal of parasitology research · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. RSC advances · 2023
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohsin AliDepartment of Veterinary Medicine, University of Veterinary and Animal Sciences, Lahore, Punjab, 54000, Pakistan.
Muhammad IjazDepartment of Veterinary Medicine, University of Veterinary and Animal Sciences, Lahore, Punjab, 54000, Pakistan. mijaz@uvas.edu.pk.
Muhammad IkramSolar Cell Applications Research Lab, Department of Physics, Government College University Lahore, Lahore, Punjab, 54000, Pakistan. dr.muhammadikram@gcu.edu.pk.ORCID http://orcid.org/0000-0001-7741-789X
Anwar Ul-HamidCore Research Facilities, King Fahd University of Petroleum and Minerals, Dhahran, 31261, Saudi Arabia.
Muhammad AvaisDepartment of Veterinary Medicine, University of Veterinary and Animal Sciences, Lahore, Punjab, 54000, Pakistan.
Aftab Ahmad AnjumDepartment of Veterinary Medicine, University of Veterinary and Animal Sciences, Lahore, Punjab, 54000, Pakistan.

Funding

Higher Education Commission, Pakistan 21-1669
6 · The paper itself

Abstract

The development of resistance against antibiotics used to treat bacterial infections along with the prevalence of medication residues presents significant public health problems globally. Antibiotic-resistant germs result in infections that are difficult or impossible to treat. Decreasing antibiotic effectiveness calls for rapid development of alternative antimicrobials. In this respect, nanoparticles (NPs) of copper oxide (CuO) manifest a latent and flexible inorganic nanostructure with noteworthy antimicrobial impact. Green synthesis of CuO NPs was performed in the current study, which was then doped with varying amounts of ginger (Zingiber officinale, ZO) and garlic (Allium sativum, AS) extracts. In low and high doses, the synthesized compound was used to measure the antimicrobial effectiveness against pathogenic Escherichia coli. The present research successfully demonstrated a renewable, eco-friendly synthesis technique with natural materials that is equally applicable to other green metal oxide NPs.

Indexed as

BactericidalBiogenic synthesisDopingE. coliGarlicGingerMastitisNanoparticles

Identifiers

PMID34542713
PMCPMC8452814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.